Advanced Pharmacotherapeutics in Cardiovascular Diseases
Your upfront cost:
11 Jul 2022
Australia’s fourth oldest university, the University of Tasmania, is highly regarded internationally for teaching and academic excellence. The university offers more than 100 undergraduate degrees and more than 50 postgraduate programs across a range of disciplines. The university offers students a diverse range of opportunities, the chance to learn from leading experts, and excellent preparation for their future careers.
Upon completion of this subject, the student should be able to:
Identify and evaluate problems associated with cardiovascular medicines using an evidence-based approach.
Critically evaluate cardiovascular medication therapy using an evidence-based approach and accepted best clinical practice to devise and justify appropriate courses of action for therapeutic management.
Employ evidence-based and contemporary clinical skills to conduct a clinical audit and demonstrate how this may influence pharmacy practice in the management of cardiovascular disease.
Demonstrate effective written and oral presentation skills to explain contemporary issues associated with cardiovascular medication therapy.
CSA722 is a self-directed, fully on-line subject, that explores a variety of disease states and their management, using a series of patient cases linked to assignment based questions, to enable the student to enhance their knowledge in the area of clinical pharmacy and pharmaceutical care.